Sulfasalazine related nephrolithiasis in patients with rheumatoid arthritis and ankylosing spondylitis
Turkish Journal of Internal Medicine · 2022
DOI: 10.46310/tjim.1058021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Internal Medicine, 2022. Verfasst von Gülşah ŞAŞAK KUZGUN und 3 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Gefördert von: none.
Abstract (Originalsprache)
Background
Sulfasalazine (SSZ) is an anti-inflammatory and immunomodulatory drug used to treat many inflammatory diseases. Bacteria in the gut metabolize SSZ to active 5-aminosalicylic acid and inactive sulfapyridine. Sulfapyridine can crystallize in the kidney. We aimed to investigate the frequency of nephrolithiasis in patients who were diagnosed with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and who received SSZ treatment retrospectively. Material and Methods We retrospectively analyzed the files of AS and RA patients in the rheumatology outpatient clinic between 2009 and 2018. We identified patients who underwent kidney ultrasonography at least six months after initiation of SSZ. One hundred six patients and 50 healthy adults were included in the study.
Results
Only eight patients (6 AS, 2 RA) had nephrolithiasis on ultrasonography, but none in the control group (p=0.046). In logistic regression analysis, no correlation was found between gender, age, vitamin D, parathyroid hormone, and urinary calcium excretion with SSZ use (p>0.05).
Conclusion
Although, it is noteworthy that these patients are prone to stone formation for various reasons. Therefore, paying attention to the patient’s hydration while using these drugs may prevent such side effects.
Förderung
- none
Zitieren
APA
KUZGUN, G. Ş., MURAT, S., ÖZKÖK, S., & KASAPOGLU, E. (2022). Sulfasalazine related nephrolithiasis in patients with rheumatoid arthritis and ankylosing spondylitis. Turkish Journal of Internal Medicine. https://doi.org/10.46310/tjim.1058021
Vancouver
KUZGUN GŞ, MURAT S, ÖZKÖK S, KASAPOGLU E. Sulfasalazine related nephrolithiasis in patients with rheumatoid arthritis and ankylosing spondylitis. Turkish Journal of Internal Medicine. 2022. doi:10.46310/tjim.1058021
BibTeX
@article{KUZGUN2022,
author = {KUZGUN, Gülşah ŞAŞAK and MURAT, Sadiye and ÖZKÖK, Serçin and KASAPOGLU, Esen},
title = {Sulfasalazine related nephrolithiasis in patients with rheumatoid arthritis and ankylosing spondylitis},
journal = {Turkish Journal of Internal Medicine},
year = {2022},
doi = {10.46310/tjim.1058021}
}
EUVIMED